Argent Biopharma Limited has released a press release.
COVID-19 Interim Trial Results Meet All Primary Objectives
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Uk distribution agreement signed for mgc pharma medicines
- Study confirms effectiveness of artemic on human immune cell
- Trading halt
- June Quarterly Activity and Cashflow Report
- Reinstatement to Official Quotation
Later from Argent Biopharma
- Jv to be established for registration of artemic in russia
- Appendix 4E and Preliminary Unaudited Financial Report
- $15M finance facility to fund revenue growth for key markets
- Mxc well positioned for tga down-schedule of cbd products
- Mxc welcomes new fca guidance for cannabis sector in the uk
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma